PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC

NCT07630363 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Advanced Renal Cell Carcinoma (RCC)
PTC
Atorvastatin
Targeted Therapy Combined With Immunotherapy

Interventions

DRUG: Axitinib
DRUG: Toripalimab
DRUG: Atorvastatin

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences